Increasing excretion of urate with displacing agents in man.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001665:Binding Sites; D003619:Dansyl Compounds / Q000097:blood; D003956:Dialysis; D005227:Fatty Acids / Q000494:pharmacology; D006073:Gout / Q000097:blood; D006801:Humans; D007684:Kidney Tubules / Q000378:metabolism; D008528:Mefenamic Acid / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D012459:Salicylates / Q000494:pharmacology; D012709:Serum Albumin / Q000378:metabolism; D013432:Sulfathiazoles / Q000494:pharmacology; D014462:Ultrafiltration; D014527:Uric Acid / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D014528:Uricosuric Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D003619:Dansyl Compounds; D005227:Fatty Acids; D012459:Salicylates; D012709:Serum Albumin; D013432:Sulfathiazoles; D014528:Uricosuric Agents; D014527:Uric Acid; D008528:Mefenamic Acid; D010653:Phenylbutazone